Home / Facilities / 3008629186

Oklahoma Blood Institute Dba Arkansas Blood Institute FDA Inspection Record

FEI 3008629186 · Inspections, Form 483s, warning letters and import refusals

Oklahoma Blood Institute Dba Arkansas Blood Institute is an FDA-inspected facility (FEI 3008629186) located in Fort Smith, AR, US. RegDataLab tracks 8 FDA inspections at this facility.

Reviewing Oklahoma Blood Institute Dba Arkansas Blood Institute as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Oklahoma Blood Institute Dba Arkansas Blood Institute yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
May 1, 2025: No Action Indicated (NAI)
Inspections on record
8 (2 VAI, 6 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
1, latest Jan 22, 2021

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
May 1, 2025No Action Indicated (NAI)No citations listed
Feb 16, 2022No Action Indicated (NAI)No citations listed
Apr 4, 2018No Action Indicated (NAI)No citations listed
Mar 24, 2016No Action Indicated (NAI)No citations listed
Jun 17, 2014No Action Indicated (NAI)No citations listed
Jul 19, 2012No Action Indicated (NAI)No citations listed
Jun 21, 2011Voluntary Action Indicated (VAI)No citations listed
Feb 9, 2010Voluntary Action Indicated (VAI)Provide proper equipment to meet requirements (21 CFR 606.60(a))

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jan 22, 2021Class IIB-0414-2021Apheresis Platelets, Leukocytes Reduced, Irradiated
Leukoreduced Irradiated Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count…

Facility details

Company
Oklahoma Blood Institute
Location
Fort Smith, AR (US)
Source
inspections

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.